

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 9.54535412 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 8.35183542 |
| 3 | positive regulation of vasculogenesis (GO:2001214) | 8.05234700 |
| 4 | positive regulation of chemokine secretion (GO:0090197) | 7.69549601 |
| 5 | regulation of chemokine secretion (GO:0090196) | 6.43981169 |
| 6 | ovulation from ovarian follicle (GO:0001542) | 6.32267449 |
| 7 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 6.25796405 |
| 8 | positive regulation of macrophage activation (GO:0043032) | 6.25258057 |
| 9 | regulation of vasculogenesis (GO:2001212) | 6.15321193 |
| 10 | glomerular filtration (GO:0003094) | 6.14632663 |
| 11 | lymphangiogenesis (GO:0001946) | 6.07186521 |
| 12 | blood vessel maturation (GO:0001955) | 5.72015605 |
| 13 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.65138842 |
| 14 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 5.63484027 |
| 15 | sprouting angiogenesis (GO:0002040) | 5.57072372 |
| 16 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 5.51594636 |
| 17 | renal filtration (GO:0097205) | 5.50109900 |
| 18 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 5.42299070 |
| 19 | negative regulation of macrophage differentiation (GO:0045650) | 5.36578313 |
| 20 | endothelial cell morphogenesis (GO:0001886) | 5.33428527 |
| 21 | regulation of gonadotropin secretion (GO:0032276) | 5.25905003 |
| 22 | negative regulation of endothelial cell migration (GO:0010596) | 5.11608642 |
| 23 | patterning of blood vessels (GO:0001569) | 4.86253766 |
| 24 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.72672514 |
| 25 | transcytosis (GO:0045056) | 4.69753361 |
| 26 | endothelial tube morphogenesis (GO:0061154) | 4.69264515 |
| 27 | morphogenesis of an endothelium (GO:0003159) | 4.69264515 |
| 28 | endothelial cell differentiation (GO:0045446) | 4.68953833 |
| 29 | surfactant homeostasis (GO:0043129) | 4.68759980 |
| 30 | angiogenesis involved in wound healing (GO:0060055) | 4.68387498 |
| 31 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.55147484 |
| 32 | negative regulation of epithelial cell migration (GO:0010633) | 4.36183092 |
| 33 | regulation of interleukin-5 production (GO:0032674) | 4.32854852 |
| 34 | heart trabecula formation (GO:0060347) | 4.19908478 |
| 35 | blood vessel endothelial cell migration (GO:0043534) | 4.04934833 |
| 36 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.97562841 |
| 37 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.93524400 |
| 38 | negative regulation of inclusion body assembly (GO:0090084) | 3.93497274 |
| 39 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.87147417 |
| 40 | regulation of endothelial cell migration (GO:0010594) | 3.86486748 |
| 41 | response to follicle-stimulating hormone (GO:0032354) | 3.84484804 |
| 42 | gamma-aminobutyric acid transport (GO:0015812) | 3.79357612 |
| 43 | regulation of positive chemotaxis (GO:0050926) | 3.73650059 |
| 44 | potassium ion import (GO:0010107) | 3.69980903 |
| 45 | cGMP-mediated signaling (GO:0019934) | 3.69271103 |
| 46 | embryonic heart tube development (GO:0035050) | 3.65676935 |
| 47 | vasculogenesis (GO:0001570) | 3.64613420 |
| 48 | endoderm formation (GO:0001706) | 3.61508342 |
| 49 | endothelial cell proliferation (GO:0001935) | 3.55545896 |
| 50 | chemical homeostasis within a tissue (GO:0048875) | 3.54963521 |
| 51 | basement membrane organization (GO:0071711) | 3.53214831 |
| 52 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.51947909 |
| 53 | * regulation of endothelial cell differentiation (GO:0045601) | 3.51924958 |
| 54 | Rap protein signal transduction (GO:0032486) | 3.51887896 |
| 55 | positive regulation of odontogenesis (GO:0042482) | 3.49968959 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.39436892 |
| 57 | positive regulation of Rap GTPase activity (GO:0032854) | 3.38593892 |
| 58 | Notch receptor processing (GO:0007220) | 3.38186917 |
| 59 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.37978930 |
| 60 | establishment of endothelial barrier (GO:0061028) | 3.37781011 |
| 61 | cellular response to cholesterol (GO:0071397) | 3.34704551 |
| 62 | Notch signaling involved in heart development (GO:0061314) | 3.30791753 |
| 63 | cellular response to sterol (GO:0036315) | 3.26791480 |
| 64 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.24650866 |
| 65 | positive regulation of endothelial cell migration (GO:0010595) | 3.23286205 |
| 66 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.22749520 |
| 67 | ovulation (GO:0030728) | 3.22225533 |
| 68 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.21063736 |
| 69 | positive regulation of cell junction assembly (GO:1901890) | 3.20577253 |
| 70 | positive regulation of focal adhesion assembly (GO:0051894) | 3.20577253 |
| 71 | vasculature development (GO:0001944) | 3.18731204 |
| 72 | regulation of epithelial cell migration (GO:0010632) | 3.18537837 |
| 73 | endothelial cell chemotaxis (GO:0035767) | 3.17867304 |
| 74 | response to fluid shear stress (GO:0034405) | 3.16949664 |
| 75 | trabecula morphogenesis (GO:0061383) | 3.15596050 |
| 76 | heart trabecula morphogenesis (GO:0061384) | 3.15368998 |
| 77 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.13473252 |
| 78 | negative regulation of Ras GTPase activity (GO:0034261) | 3.13128088 |
| 79 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.13028659 |
| 80 | negative regulation of interferon-gamma production (GO:0032689) | 3.12786656 |
| 81 | negative regulation of angiogenesis (GO:0016525) | 3.11975315 |
| 82 | substrate-dependent cell migration (GO:0006929) | 3.11483175 |
| 83 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.08819741 |
| 84 | * angiogenesis (GO:0001525) | 3.07976812 |
| 85 | positive regulation of endothelial cell proliferation (GO:0001938) | 3.07672696 |
| 86 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.07121225 |
| 87 | response to laminar fluid shear stress (GO:0034616) | 3.05733555 |
| 88 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.04177947 |
| 89 | phagocytosis, recognition (GO:0006910) | 3.04067249 |
| 90 | endothelial cell migration (GO:0043542) | 3.03664640 |
| 91 | negative regulation of blood vessel morphogenesis (GO:2000181) | 3.01809460 |
| 92 | positive regulation of receptor recycling (GO:0001921) | 2.99343578 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98765239 |
| 94 | hemoglobin metabolic process (GO:0020027) | 2.94670880 |
| 95 | regulation of actin filament-based movement (GO:1903115) | 2.94312475 |
| 96 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.92819766 |
| 97 | positive regulation of tyrosine phosphorylation of Stat3 protein (GO:0042517) | 2.90504000 |
| 98 | positive regulation of adherens junction organization (GO:1903393) | 2.89171164 |
| 99 | regulation of sarcomere organization (GO:0060297) | 2.89062881 |
| 100 | adhesion of symbiont to host (GO:0044406) | 2.88817568 |
| 101 | negative regulation of vascular permeability (GO:0043116) | 2.88330393 |
| 102 | regulation of Rap GTPase activity (GO:0032317) | 2.88065591 |
| 103 | regulation of synapse structural plasticity (GO:0051823) | 2.86944878 |
| 104 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.85203105 |
| 105 | negative regulation of vasculature development (GO:1901343) | 2.83259472 |
| 106 | blood vessel remodeling (GO:0001974) | 2.83193961 |
| 107 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.80779549 |
| 108 | cAMP biosynthetic process (GO:0006171) | 2.79736327 |
| 109 | sodium-independent organic anion transport (GO:0043252) | 2.79412269 |
| 110 | positive regulation of angiogenesis (GO:0045766) | 2.78276248 |
| 111 | vocalization behavior (GO:0071625) | 2.78065170 |
| 112 | endocardial cushion morphogenesis (GO:0003203) | 2.77754495 |
| 113 | cellular response to fluid shear stress (GO:0071498) | 2.76775847 |
| 114 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.75748780 |
| 115 | positive regulation of protein kinase C signaling (GO:0090037) | 2.75727038 |
| 116 | artery development (GO:0060840) | 2.75708150 |
| 117 | blood vessel morphogenesis (GO:0048514) | 2.75294340 |
| 118 | trabecula formation (GO:0060343) | 2.74463973 |
| 119 | arginine catabolic process (GO:0006527) | 2.74343498 |
| 120 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.74266408 |
| 121 | histamine secretion (GO:0001821) | 2.73807088 |
| 122 | venous blood vessel morphogenesis (GO:0048845) | 2.73542228 |
| 123 | ganglion development (GO:0061548) | 2.72820625 |
| 124 | endocrine hormone secretion (GO:0060986) | 2.72614923 |
| 125 | regulation of relaxation of muscle (GO:1901077) | 2.72358833 |
| 126 | negative regulation of platelet activation (GO:0010544) | 2.72274038 |
| 127 | regulation of endothelial cell proliferation (GO:0001936) | 2.72196201 |
| 128 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.69217869 |
| 129 | regulation of cellular extravasation (GO:0002691) | 2.68892378 |
| 130 | cAMP catabolic process (GO:0006198) | 2.68445093 |
| 131 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.68397337 |
| 132 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.68388680 |
| 133 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.67011032 |
| 134 | cellular response to gonadotropin stimulus (GO:0071371) | 2.66193793 |
| 135 | regulation of macrophage activation (GO:0043030) | 2.65890887 |
| 136 | atrioventricular valve morphogenesis (GO:0003181) | 2.65732356 |
| 137 | melanin biosynthetic process (GO:0042438) | 2.65345318 |
| 138 | cellular potassium ion homeostasis (GO:0030007) | 2.64266314 |
| 139 | positive regulation of catenin import into nucleus (GO:0035413) | 2.63975548 |
| 140 | cyclic nucleotide catabolic process (GO:0009214) | 2.61909404 |
| 141 | regulation of axon guidance (GO:1902667) | 2.61443566 |
| 142 | mesodermal cell differentiation (GO:0048333) | 2.61194060 |
| 143 | axon ensheathment in central nervous system (GO:0032291) | 2.59745842 |
| 144 | central nervous system myelination (GO:0022010) | 2.59745842 |
| 145 | nephron epithelium development (GO:0072009) | 2.57716740 |
| 146 | auditory behavior (GO:0031223) | 2.56187588 |
| 147 | eyelid development in camera-type eye (GO:0061029) | 2.53776114 |
| 148 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.52739798 |
| 149 | regulation of macrophage differentiation (GO:0045649) | 2.51211935 |
| 150 | enteric nervous system development (GO:0048484) | 2.50879705 |
| 151 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.50465323 |
| 152 | cardiac myofibril assembly (GO:0055003) | 2.50075598 |
| 153 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.48809088 |
| 154 | negative regulation of axon guidance (GO:1902668) | 2.46999108 |
| 155 | melanin metabolic process (GO:0006582) | 2.44463514 |
| 156 | mesenchymal cell development (GO:0014031) | 2.43925688 |
| 157 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.42439016 |
| 158 | activin receptor signaling pathway (GO:0032924) | 2.42413385 |
| 159 | sodium ion export (GO:0071436) | 2.42397676 |
| 160 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.42000596 |
| 161 | regulation of T-helper 1 type immune response (GO:0002825) | 2.41414868 |
| 162 | positive regulation of actin filament depolymerization (GO:0030836) | 2.40128245 |
| 163 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.39360171 |
| 164 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.39360171 |
| 165 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.39360171 |
| 166 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.39097545 |
| 167 | vascular smooth muscle contraction (GO:0014829) | 2.38761759 |
| 168 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.33809558 |
| 169 | coronary vasculature morphogenesis (GO:0060977) | 2.33503526 |
| 170 | negative regulation of complement activation (GO:0045916) | 2.32418080 |
| 171 | lymph vessel development (GO:0001945) | 11.2720208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.71330072 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.36881839 |
| 3 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.92531122 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.70450615 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.32383046 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.32117541 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.30160704 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.01152173 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.77938357 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.77748646 |
| 11 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.37654802 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.32426695 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.18360083 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.14863524 |
| 15 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.06610602 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.02526744 |
| 17 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.02506885 |
| 18 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.02506885 |
| 19 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.02506885 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99326341 |
| 21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.90897042 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.88364354 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87974481 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87938427 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.86630754 |
| 26 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.81646232 |
| 27 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.80348389 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80028599 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.78315618 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76259903 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76019897 |
| 32 | CJUN_26792858_Chip-Seq_BT549_Human | 1.75092515 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72771682 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64859275 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64540871 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.61308473 |
| 37 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59447903 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59297911 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58015780 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.55189528 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55175485 |
| 42 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.53457043 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.51090637 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50940406 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50679991 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49051943 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45973088 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45192297 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.43463465 |
| 50 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43279571 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41692523 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41413579 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41393637 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40678049 |
| 55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38721232 |
| 56 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.37502682 |
| 57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36218749 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31033416 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28893874 |
| 60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27370452 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26730445 |
| 62 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25751212 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25023958 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20376885 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20180614 |
| 66 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19751102 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19751102 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19196299 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18010187 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18000624 |
| 71 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17208410 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17187474 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16639830 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16210918 |
| 75 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.15926407 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15441444 |
| 77 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14020349 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13937232 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13543549 |
| 80 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13543549 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12972689 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12902947 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12902947 |
| 84 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12804958 |
| 85 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10987092 |
| 86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10814608 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09943229 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09668571 |
| 89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09653197 |
| 90 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09069231 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08774141 |
| 92 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08649345 |
| 93 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08561839 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08251128 |
| 95 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07981468 |
| 96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07398275 |
| 97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06740901 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06557889 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05641168 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03927849 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03201752 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02868732 |
| 103 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01846068 |
| 104 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01323933 |
| 105 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00974049 |
| 106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00924219 |
| 107 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00692635 |
| 108 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00681759 |
| 109 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00521750 |
| 110 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00022735 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99050427 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98499688 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98450113 |
| 114 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98111845 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97981918 |
| 116 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97978361 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97072778 |
| 118 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96951468 |
| 119 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96887087 |
| 120 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.96777335 |
| 121 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96156619 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94758734 |
| 123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94574866 |
| 124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94463400 |
| 125 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94399810 |
| 126 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94399810 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93519489 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93334405 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93193124 |
| 130 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92829434 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92788914 |
| 132 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92480434 |
| 133 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92027638 |
| 134 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91741272 |
| 135 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91642024 |
| 136 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91142296 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90638789 |
| 138 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.90346989 |
| 139 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89764314 |
| 140 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88799799 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88658092 |
| 142 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87788220 |
| 143 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87652966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001879_abnormal_lymphatic_vessel | 7.26212343 |
| 2 | MP0010368_abnormal_lymphatic_system | 6.71948169 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 5.55892907 |
| 4 | MP0003136_yellow_coat_color | 4.76339142 |
| 5 | MP0005171_absent_coat_pigmentation | 4.13062946 |
| 6 | MP0005187_abnormal_penis_morphology | 4.12183816 |
| 7 | MP0004272_abnormal_basement_membrane | 4.02273730 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.94999841 |
| 9 | MP0003724_increased_susceptibility_to | 3.91001303 |
| 10 | MP0006054_spinal_hemorrhage | 3.57191644 |
| 11 | MP0004147_increased_porphyrin_level | 3.38062169 |
| 12 | MP0003828_pulmonary_edema | 3.35778547 |
| 13 | MP0009278_abnormal_bone_marrow | 2.94497084 |
| 14 | MP0005623_abnormal_meninges_morphology | 2.66121724 |
| 15 | MP0001188_hyperpigmentation | 2.25406327 |
| 16 | MP0000767_abnormal_smooth_muscle | 2.23623802 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.14705716 |
| 18 | MP0004484_altered_response_of | 1.88617998 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.85016626 |
| 20 | MP0003279_aneurysm | 1.68950551 |
| 21 | MP0006138_congestive_heart_failure | 1.67122562 |
| 22 | MP0003950_abnormal_plasma_membrane | 1.66792201 |
| 23 | MP0002127_abnormal_cardiovascular_syste | 1.58438286 |
| 24 | MP0003943_abnormal_hepatobiliary_system | 1.57469478 |
| 25 | MP0005423_abnormal_somatic_nervous | 1.56418293 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.55714802 |
| 27 | MP0000249_abnormal_blood_vessel | 1.55684474 |
| 28 | MP0005165_increased_susceptibility_to | 1.52918497 |
| 29 | MP0003315_abnormal_perineum_morphology | 1.52011580 |
| 30 | MP0001299_abnormal_eye_distance/ | 1.51167577 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.49408760 |
| 32 | MP0002925_abnormal_cardiovascular_devel | 1.49088714 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.48805567 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.48295066 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.48295066 |
| 36 | MP0003091_abnormal_cell_migration | 1.46932298 |
| 37 | MP0004885_abnormal_endolymph | 1.46049989 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.43402813 |
| 39 | MP0008995_early_reproductive_senescence | 1.43205320 |
| 40 | MP0005503_abnormal_tendon_morphology | 1.40686093 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.40435995 |
| 42 | MP0002006_tumorigenesis | 1.40362363 |
| 43 | MP0004130_abnormal_muscle_cell | 1.38222668 |
| 44 | MP0009697_abnormal_copulation | 1.37165894 |
| 45 | MP0005595_abnormal_vascular_smooth | 1.33008837 |
| 46 | MP0005408_hypopigmentation | 1.32716968 |
| 47 | MP0009745_abnormal_behavioral_response | 1.32570358 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.31319235 |
| 49 | MP0001851_eye_inflammation | 1.31242650 |
| 50 | MP0004883_abnormal_blood_vessel | 1.25233373 |
| 51 | MP0002128_abnormal_blood_circulation | 1.25168315 |
| 52 | MP0001614_abnormal_blood_vessel | 1.22016598 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.21892664 |
| 54 | MP0005253_abnormal_eye_physiology | 1.19106406 |
| 55 | MP0002295_abnormal_pulmonary_circulatio | 1.18557514 |
| 56 | MP0000751_myopathy | 1.18342534 |
| 57 | MP0004215_abnormal_myocardial_fiber | 1.17975500 |
| 58 | MP0001915_intracranial_hemorrhage | 1.17872793 |
| 59 | MP0003283_abnormal_digestive_organ | 1.17356992 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.14259262 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.13926613 |
| 62 | MP0001486_abnormal_startle_reflex | 1.13083644 |
| 63 | MP0003646_muscle_fatigue | 1.09475741 |
| 64 | MP0002064_seizures | 1.08485096 |
| 65 | MP0003303_peritoneal_inflammation | 1.07594095 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.06518828 |
| 67 | MP0003011_delayed_dark_adaptation | 1.06196184 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.05434115 |
| 69 | MP0003941_abnormal_skin_development | 1.03865093 |
| 70 | MP0003045_fibrosis | 1.01980704 |
| 71 | MP0005164_abnormal_response_to | 1.01100540 |
| 72 | MP0001784_abnormal_fluid_regulation | 1.00506125 |
| 73 | MP0009384_cardiac_valve_regurgitation | 0.99387369 |
| 74 | MP0000230_abnormal_systemic_arterial | 0.98870546 |
| 75 | MP0003880_abnormal_central_pattern | 0.98082707 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 0.98007763 |
| 77 | MP0000003_abnormal_adipose_tissue | 0.95952451 |
| 78 | MP0005375_adipose_tissue_phenotype | 0.95126951 |
| 79 | MP0000516_abnormal_urinary_system | 0.93487197 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 0.93487197 |
| 81 | MP0005275_abnormal_skin_tensile | 0.93462774 |
| 82 | MP0002009_preneoplasia | 0.92745759 |
| 83 | MP0001270_distended_abdomen | 0.92359509 |
| 84 | MP0010630_abnormal_cardiac_muscle | 0.92317080 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.88843299 |
| 86 | MP0002272_abnormal_nervous_system | 0.88696902 |
| 87 | MP0001873_stomach_inflammation | 0.87264322 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.87104739 |
| 89 | MP0002938_white_spotting | 0.85567152 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.85350194 |
| 91 | MP0000343_altered_response_to | 0.83429859 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 0.82626523 |
| 93 | MP0002086_abnormal_extraembryonic_tissu | 0.81932301 |
| 94 | MP0005385_cardiovascular_system_phenoty | 0.81872055 |
| 95 | MP0001544_abnormal_cardiovascular_syste | 0.81872055 |
| 96 | MP0004043_abnormal_pH_regulation | 0.80913509 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.79565090 |
| 98 | MP0003690_abnormal_glial_cell | 0.79487048 |
| 99 | MP0000749_muscle_degeneration | 0.78512099 |
| 100 | MP0005330_cardiomyopathy | 0.77779520 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.77739978 |
| 102 | MP0001984_abnormal_olfaction | 0.76383350 |
| 103 | MP0006072_abnormal_retinal_apoptosis | 0.76013119 |
| 104 | MP0003635_abnormal_synaptic_transmissio | 0.74667845 |
| 105 | MP0008775_abnormal_heart_ventricle | 0.74555556 |
| 106 | MP0004085_abnormal_heartbeat | 0.74145180 |
| 107 | MP0000266_abnormal_heart_morphology | 0.73176517 |
| 108 | MP0002735_abnormal_chemical_nociception | 0.72754881 |
| 109 | MP0005670_abnormal_white_adipose | 0.71507439 |
| 110 | MP0002972_abnormal_cardiac_muscle | 0.71229402 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.69795455 |
| 112 | MP0005409_darkened_coat_color | 0.69253085 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.68680848 |
| 114 | MP0002108_abnormal_muscle_morphology | 0.67037160 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.66489101 |
| 116 | MP0002063_abnormal_learning/memory/cond | 0.64921902 |
| 117 | MP0002572_abnormal_emotion/affect_behav | 0.64889305 |
| 118 | MP0005388_respiratory_system_phenotype | 0.64653724 |
| 119 | MP0002133_abnormal_respiratory_system | 0.64653724 |
| 120 | MP0009046_muscle_twitch | 0.64191097 |
| 121 | MP0004808_abnormal_hematopoietic_stem | 0.63054291 |
| 122 | MP0003075_altered_response_to | 0.63032669 |
| 123 | MP0003984_embryonic_growth_retardation | 0.62013100 |
| 124 | MP0005508_abnormal_skeleton_morphology | 0.61766914 |
| 125 | MP0005620_abnormal_muscle_contractility | 0.61737606 |
| 126 | MP0002088_abnormal_embryonic_growth/wei | 0.61031307 |
| 127 | MP0003633_abnormal_nervous_system | 0.60975829 |
| 128 | MP0010234_abnormal_vibrissa_follicle | 0.60741975 |
| 129 | MP0000534_abnormal_ureter_morphology | 0.60376934 |
| 130 | MP0001440_abnormal_grooming_behavior | 0.60230586 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.59936361 |
| 132 | MP0001191_abnormal_skin_condition | 0.59370783 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.58900147 |
| 134 | MP0004036_abnormal_muscle_relaxation | 0.58859374 |
| 135 | MP0000733_abnormal_muscle_development | 0.57315286 |
| 136 | MP0002166_altered_tumor_susceptibility | 0.56843441 |
| 137 | MP0003385_abnormal_body_wall | 0.52992602 |
| 138 | MP0003935_abnormal_craniofacial_develop | 0.51262487 |
| 139 | MP0002928_abnormal_bile_duct | 0.50642637 |
| 140 | MP0001958_emphysema | 0.49999506 |
| 141 | MP0003638_abnormal_response/metabolism_ | 0.49671609 |
| 142 | MP0003448_altered_tumor_morphology | 0.49046300 |
| 143 | MP0002896_abnormal_bone_mineralization | 0.47244536 |
| 144 | MP0001542_abnormal_bone_strength | 0.46188806 |
| 145 | MP0002098_abnormal_vibrissa_morphology | 0.46118808 |
| 146 | MP0009764_decreased_sensitivity_to | 0.44806184 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.42777740 |
| 148 | MP0005380_embryogenesis_phenotype | 0.42366810 |
| 149 | MP0001672_abnormal_embryogenesis/_devel | 0.42366810 |
| 150 | MP0002254_reproductive_system_inflammat | 0.41303656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent hand (HP:0004050) | 6.84192182 |
| 2 | Adactyly (HP:0009776) | 6.31103158 |
| 3 | Capillary hemangiomas (HP:0005306) | 6.18040646 |
| 4 | Esophageal varix (HP:0002040) | 5.79354850 |
| 5 | Polycythemia (HP:0001901) | 5.62311890 |
| 6 | Nonimmune hydrops fetalis (HP:0001790) | 5.16946824 |
| 7 | Hematochezia (HP:0002573) | 4.59936618 |
| 8 | Blue irides (HP:0000635) | 4.55705504 |
| 9 | Portal hypertension (HP:0001409) | 4.51972943 |
| 10 | Porencephaly (HP:0002132) | 4.48376928 |
| 11 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.47388395 |
| 12 | Abnormality of the hepatic vasculature (HP:0006707) | 4.38296664 |
| 13 | Congenital, generalized hypertrichosis (HP:0004540) | 4.36543805 |
| 14 | Aplasia cutis congenita (HP:0001057) | 4.29999534 |
| 15 | Spontaneous hematomas (HP:0007420) | 4.23541856 |
| 16 | Skull defect (HP:0001362) | 4.09952849 |
| 17 | Hemiparesis (HP:0001269) | 4.04039783 |
| 18 | Abnormality of the ischium (HP:0003174) | 3.93050112 |
| 19 | Hypoglycemic seizures (HP:0002173) | 3.85211230 |
| 20 | Follicular hyperkeratosis (HP:0007502) | 3.82248607 |
| 21 | Distal lower limb muscle weakness (HP:0009053) | 3.63402487 |
| 22 | Hypoplastic ischia (HP:0003175) | 3.47466760 |
| 23 | Supraventricular tachycardia (HP:0004755) | 3.42613684 |
| 24 | Papilledema (HP:0001085) | 3.41646262 |
| 25 | Increased connective tissue (HP:0009025) | 3.39116889 |
| 26 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.36740725 |
| 27 | Large for gestational age (HP:0001520) | 3.36465555 |
| 28 | Bundle branch block (HP:0011710) | 3.34998015 |
| 29 | White forelock (HP:0002211) | 3.27064428 |
| 30 | Sudden death (HP:0001699) | 3.15828291 |
| 31 | Hypoplasia of the fovea (HP:0007750) | 3.15025316 |
| 32 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.15025316 |
| 33 | Focal seizures (HP:0007359) | 3.01625124 |
| 34 | Hypoglycemic coma (HP:0001325) | 2.93551008 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.92869090 |
| 36 | Subacute progressive viral hepatitis (HP:0006572) | 2.87735401 |
| 37 | Pulmonary artery stenosis (HP:0004415) | 2.81563147 |
| 38 | Abnormality of the nasal septum (HP:0000419) | 2.81212294 |
| 39 | Cerebral hemorrhage (HP:0001342) | 2.74970961 |
| 40 | Absent toe (HP:0010760) | 2.74399197 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.73547797 |
| 42 | Spinal rigidity (HP:0003306) | 2.73519428 |
| 43 | Prominent supraorbital ridges (HP:0000336) | 2.70136105 |
| 44 | Hypoplasia of the iris (HP:0007676) | 2.67009973 |
| 45 | Abnormality of the fovea (HP:0000493) | 2.66471265 |
| 46 | Cortical dysplasia (HP:0002539) | 2.65553819 |
| 47 | Conjunctival telangiectasia (HP:0000524) | 2.65378082 |
| 48 | Hyperkalemia (HP:0002153) | 2.65374300 |
| 49 | Symptomatic seizures (HP:0011145) | 2.65235071 |
| 50 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.65214407 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.64873905 |
| 52 | Patchy hypopigmentation of hair (HP:0011365) | 2.63884550 |
| 53 | Syncope (HP:0001279) | 2.61821241 |
| 54 | Broad metatarsal (HP:0001783) | 2.59340495 |
| 55 | Lipoatrophy (HP:0100578) | 2.57955610 |
| 56 | Joint hemorrhage (HP:0005261) | 2.57063238 |
| 57 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.56611426 |
| 58 | Aortic aneurysm (HP:0004942) | 2.55423390 |
| 59 | Stenosis of the external auditory canal (HP:0000402) | 2.54998337 |
| 60 | Focal motor seizures (HP:0011153) | 2.53384191 |
| 61 | Heart block (HP:0012722) | 2.51952294 |
| 62 | Abnormality of chromosome segregation (HP:0002916) | 2.50751778 |
| 63 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.50384024 |
| 64 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.50384024 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 2.50310363 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.47539419 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.47395326 |
| 68 | Myocardial infarction (HP:0001658) | 2.45010538 |
| 69 | Fatigue (HP:0012378) | 2.43268068 |
| 70 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.41589370 |
| 71 | Atonic seizures (HP:0010819) | 2.40954902 |
| 72 | Hypopigmentation of the fundus (HP:0007894) | 2.40617668 |
| 73 | Asymmetry of the thorax (HP:0001555) | 2.40504057 |
| 74 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.38867992 |
| 75 | Cutis marmorata (HP:0000965) | 2.38271351 |
| 76 | Atrioventricular block (HP:0001678) | 2.35608219 |
| 77 | Pulmonary hypertension (HP:0002092) | 2.35328334 |
| 78 | Abnormality of secondary sexual hair (HP:0009888) | 2.34025880 |
| 79 | Abnormality of the axillary hair (HP:0100134) | 2.34025880 |
| 80 | Hypokalemic alkalosis (HP:0001949) | 2.30982123 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29011436 |
| 82 | Growth hormone excess (HP:0000845) | 2.25496280 |
| 83 | Lymphangioma (HP:0100764) | 2.24866634 |
| 84 | Facial diplegia (HP:0001349) | 2.23800600 |
| 85 | Pigmentary retinal degeneration (HP:0001146) | 2.23226016 |
| 86 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.22840428 |
| 87 | Muscle stiffness (HP:0003552) | 2.20993231 |
| 88 | Accelerated skeletal maturation (HP:0005616) | 2.18190131 |
| 89 | Absent eyebrow (HP:0002223) | 2.16575659 |
| 90 | Ventricular tachycardia (HP:0004756) | 2.15511977 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 2.13972050 |
| 92 | Hypotrichosis (HP:0001006) | 2.13634509 |
| 93 | Acanthosis nigricans (HP:0000956) | 2.12238260 |
| 94 | Venous insufficiency (HP:0005293) | 2.09197359 |
| 95 | Lymphedema (HP:0001004) | 2.08667420 |
| 96 | Abnormality of the calf musculature (HP:0001430) | 2.08602360 |
| 97 | Distal lower limb amyotrophy (HP:0008944) | 2.06761659 |
| 98 | Generalized myoclonic seizures (HP:0002123) | 2.05712256 |
| 99 | Atrial fibrillation (HP:0005110) | 2.05523318 |
| 100 | Ocular albinism (HP:0001107) | 2.04761823 |
| 101 | Bifid uvula (HP:0000193) | 2.03213882 |
| 102 | Short hallux (HP:0010109) | 2.02630264 |
| 103 | Action tremor (HP:0002345) | 2.02592632 |
| 104 | Scotoma (HP:0000575) | 2.01452400 |
| 105 | Supraventricular arrhythmia (HP:0005115) | 1.98998793 |
| 106 | Hyporeflexia of lower limbs (HP:0002600) | 1.98947967 |
| 107 | Exercise-induced muscle cramps (HP:0003710) | 1.97973911 |
| 108 | Hemangiomatosis (HP:0007461) | 1.97719079 |
| 109 | Oligomenorrhea (HP:0000876) | 1.97321505 |
| 110 | Myotonia (HP:0002486) | 1.96651301 |
| 111 | Calf muscle hypertrophy (HP:0008981) | 1.95915655 |
| 112 | Annular pancreas (HP:0001734) | 1.95910874 |
| 113 | Venous abnormality (HP:0002624) | 1.94893304 |
| 114 | Lower limb amyotrophy (HP:0007210) | 1.94528908 |
| 115 | Prolonged bleeding time (HP:0003010) | 1.93693809 |
| 116 | Submucous cleft hard palate (HP:0000176) | 1.92797363 |
| 117 | Short humerus (HP:0005792) | 1.92630977 |
| 118 | Febrile seizures (HP:0002373) | 1.91568391 |
| 119 | Congenital stationary night blindness (HP:0007642) | 1.91073498 |
| 120 | Vascular tortuosity (HP:0004948) | 1.88704924 |
| 121 | Asymmetric septal hypertrophy (HP:0001670) | 1.88310183 |
| 122 | Abnormal drinking behavior (HP:0030082) | 1.87993367 |
| 123 | Polydipsia (HP:0001959) | 1.87993367 |
| 124 | Neoplasm of the heart (HP:0100544) | 1.86389270 |
| 125 | Ventricular arrhythmia (HP:0004308) | 1.85870965 |
| 126 | Axonal loss (HP:0003447) | 1.85047222 |
| 127 | Prolonged QT interval (HP:0001657) | 1.84876548 |
| 128 | Dysdiadochokinesis (HP:0002075) | 1.84022275 |
| 129 | Thick nail (HP:0001805) | 1.83717687 |
| 130 | Large hands (HP:0001176) | 1.83477758 |
| 131 | Increased circulating renin level (HP:0000848) | 1.83194303 |
| 132 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.82583628 |
| 133 | Pulmonary embolism (HP:0002204) | 1.82081858 |
| 134 | Primary atrial arrhythmia (HP:0001692) | 1.81936251 |
| 135 | Confusion (HP:0001289) | 1.81871473 |
| 136 | Difficulty running (HP:0009046) | 1.81573205 |
| 137 | Pheochromocytoma (HP:0002666) | 1.80379880 |
| 138 | Shallow orbits (HP:0000586) | 1.79244532 |
| 139 | Bone cyst (HP:0012062) | 1.78994677 |
| 140 | Subaortic stenosis (HP:0001682) | 1.78830323 |
| 141 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.78830323 |
| 142 | Muscular dystrophy (HP:0003560) | 1.78796748 |
| 143 | Areflexia of lower limbs (HP:0002522) | 1.78492676 |
| 144 | Muscle fibrillation (HP:0010546) | 1.77949542 |
| 145 | Tubular atrophy (HP:0000092) | 1.77945391 |
| 146 | Absent eyelashes (HP:0000561) | 1.77831980 |
| 147 | Generalized hypopigmentation of hair (HP:0011358) | 1.77830259 |
| 148 | Congenital hepatic fibrosis (HP:0002612) | 1.76854462 |
| 149 | Decreased central vision (HP:0007663) | 1.75830532 |
| 150 | Corneal dystrophy (HP:0001131) | 1.74543634 |
| 151 | Preaxial foot polydactyly (HP:0001841) | 1.74005832 |
| 152 | Abnormal auditory evoked potentials (HP:0006958) | 1.73890003 |
| 153 | EMG: myopathic abnormalities (HP:0003458) | 1.73681017 |
| 154 | Facial shape deformation (HP:0011334) | 1.73543687 |
| 155 | Potter facies (HP:0002009) | 1.73543687 |
| 156 | Menorrhagia (HP:0000132) | 1.73494708 |
| 157 | Abnormal hemoglobin (HP:0011902) | 1.71419760 |
| 158 | Alopecia of scalp (HP:0002293) | 1.70664288 |
| 159 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.70358625 |
| 160 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.69822144 |
| 161 | Microcytic anemia (HP:0001935) | 1.69770246 |
| 162 | Hemiplegia (HP:0002301) | 1.69738945 |
| 163 | Hydroureter (HP:0000072) | 1.69616827 |
| 164 | Visceral angiomatosis (HP:0100761) | 1.69445614 |
| 165 | Aortic valve stenosis (HP:0001650) | 1.67035797 |
| 166 | Colitis (HP:0002583) | 1.66761407 |
| 167 | Tetraparesis (HP:0002273) | 1.66472451 |
| 168 | Difficulty climbing stairs (HP:0003551) | 1.66376842 |
| 169 | Leiomyosarcoma (HP:0100243) | 1.65755036 |
| 170 | Uterine leiomyosarcoma (HP:0002891) | 1.65755036 |
| 171 | Abnormality of binocular vision (HP:0011514) | 1.65750063 |
| 172 | Diplopia (HP:0000651) | 1.65750063 |
| 173 | Thickened helices (HP:0000391) | 1.65360767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.14663220 |
| 2 | KDR | 9.08037491 |
| 3 | RIPK1 | 3.76521776 |
| 4 | TGFBR2 | 2.42965310 |
| 5 | PDK2 | 2.35735424 |
| 6 | INSRR | 2.30832874 |
| 7 | STK39 | 2.27663854 |
| 8 | PTK2B | 2.18015072 |
| 9 | TGFBR1 | 2.05746833 |
| 10 | GRK1 | 2.00135112 |
| 11 | AKT3 | 1.86436594 |
| 12 | CCNB1 | 1.75715533 |
| 13 | MAPK15 | 1.73064285 |
| 14 | EPHA3 | 1.58256503 |
| 15 | CDK3 | 1.55182768 |
| 16 | MAPK12 | 1.54155752 |
| 17 | MAPK7 | 1.53182200 |
| 18 | PINK1 | 1.43606854 |
| 19 | WEE1 | 1.38015693 |
| 20 | OBSCN | 1.26866310 |
| 21 | NLK | 1.26035659 |
| 22 | EPHA4 | 1.25133059 |
| 23 | PRKG2 | 1.21577382 |
| 24 | MARK1 | 1.20506604 |
| 25 | FER | 1.20388109 |
| 26 | PTK6 | 1.16369953 |
| 27 | EPHB2 | 1.14480768 |
| 28 | PKN1 | 1.08289814 |
| 29 | BMPR2 | 1.08277220 |
| 30 | MAPKAPK5 | 1.07261538 |
| 31 | PAK3 | 1.06849779 |
| 32 | MAP3K3 | 1.06416080 |
| 33 | NTRK3 | 1.06155620 |
| 34 | MAP3K14 | 1.05996510 |
| 35 | KIT | 1.02706262 |
| 36 | NUAK1 | 1.02051151 |
| 37 | DAPK2 | 1.01037760 |
| 38 | TTN | 1.00809264 |
| 39 | TSSK6 | 0.99984945 |
| 40 | DDR2 | 0.98113915 |
| 41 | TRPM7 | 0.96166451 |
| 42 | CSK | 0.95690568 |
| 43 | STK38L | 0.94735738 |
| 44 | PHKG1 | 0.94603292 |
| 45 | PHKG2 | 0.94603292 |
| 46 | FRK | 0.93027686 |
| 47 | SGK2 | 0.91985537 |
| 48 | PIM2 | 0.91484073 |
| 49 | PIK3CA | 0.91356066 |
| 50 | IRAK1 | 0.90043140 |
| 51 | IRAK3 | 0.85640307 |
| 52 | ROCK1 | 0.84630338 |
| 53 | TAOK3 | 0.82234695 |
| 54 | FGFR2 | 0.81885831 |
| 55 | GSK3A | 0.81539256 |
| 56 | NEK6 | 0.81215237 |
| 57 | LATS1 | 0.80216490 |
| 58 | WNK4 | 0.79760277 |
| 59 | FES | 0.78893307 |
| 60 | EPHA2 | 0.78751418 |
| 61 | PRKD3 | 0.77830733 |
| 62 | CAMK2D | 0.77778375 |
| 63 | CAMK2A | 0.77306586 |
| 64 | BMPR1B | 0.76483479 |
| 65 | OXSR1 | 0.74980807 |
| 66 | MAP4K2 | 0.74504783 |
| 67 | DMPK | 0.73132787 |
| 68 | BCR | 0.72430620 |
| 69 | ADRBK1 | 0.71610217 |
| 70 | TEC | 0.69535198 |
| 71 | UHMK1 | 0.68837980 |
| 72 | PRKAA2 | 0.68608962 |
| 73 | MAPK13 | 0.67916361 |
| 74 | MARK3 | 0.66645422 |
| 75 | MAP2K2 | 0.64462773 |
| 76 | NTRK2 | 0.63455378 |
| 77 | FGR | 0.63295290 |
| 78 | IRAK2 | 0.63229848 |
| 79 | PAK6 | 0.62412420 |
| 80 | IGF1R | 0.61894489 |
| 81 | PDGFRA | 0.61282441 |
| 82 | ITK | 0.60813521 |
| 83 | STK24 | 0.60298859 |
| 84 | CDK9 | 0.59708294 |
| 85 | MAP3K2 | 0.59656488 |
| 86 | MYLK | 0.59464177 |
| 87 | CASK | 0.56515141 |
| 88 | CDC42BPA | 0.54783950 |
| 89 | CAMK2G | 0.54522755 |
| 90 | PTK2 | 0.53610768 |
| 91 | CSNK1A1L | 0.51696047 |
| 92 | CAMK1G | 0.51340920 |
| 93 | PRPF4B | 0.50216441 |
| 94 | AKT2 | 0.50167061 |
| 95 | PAK4 | 0.49942542 |
| 96 | PRKCG | 0.49550717 |
| 97 | CDK8 | 0.49260665 |
| 98 | PRKG1 | 0.48926993 |
| 99 | YES1 | 0.48696070 |
| 100 | MET | 0.48482519 |
| 101 | TBK1 | 0.48386100 |
| 102 | CAMKK2 | 0.47787084 |
| 103 | MKNK2 | 0.47229958 |
| 104 | FGFR3 | 0.46145614 |
| 105 | PIM1 | 0.44040486 |
| 106 | MUSK | 0.43402184 |
| 107 | ZAK | 0.43031951 |
| 108 | MAP3K7 | 0.42796918 |
| 109 | PRKD1 | 0.42059589 |
| 110 | BMX | 0.41802366 |
| 111 | INSR | 0.41791980 |
| 112 | MAPK4 | 0.41525991 |
| 113 | CAMK2B | 0.39987307 |
| 114 | MAP2K3 | 0.39986480 |
| 115 | EPHB1 | 0.39737061 |
| 116 | RPS6KA5 | 0.38967015 |
| 117 | PRKD2 | 0.38950207 |
| 118 | JAK1 | 0.37897081 |
| 119 | PDGFRB | 0.36534373 |
| 120 | CLK1 | 0.36433478 |
| 121 | EGFR | 0.35707861 |
| 122 | IKBKE | 0.35660921 |
| 123 | PRKCE | 0.34802612 |
| 124 | ABL1 | 0.34288176 |
| 125 | PNCK | 0.34002265 |
| 126 | PRKCH | 0.33700582 |
| 127 | PRKAA1 | 0.33404427 |
| 128 | TYRO3 | 0.31486447 |
| 129 | PLK2 | 0.29638025 |
| 130 | MAP2K1 | 0.28355257 |
| 131 | STK3 | 0.25878741 |
| 132 | SRC | 0.25626752 |
| 133 | EIF2AK2 | 0.25059890 |
| 134 | STK11 | 0.24880098 |
| 135 | DYRK1B | 0.24718016 |
| 136 | CSNK1G1 | 0.24321346 |
| 137 | CHUK | 0.23381300 |
| 138 | JAK3 | 0.23189434 |
| 139 | LATS2 | 0.22449659 |
| 140 | MAPKAPK3 | 0.22370120 |
| 141 | GRK5 | 0.22227506 |
| 142 | CDK6 | 0.20892456 |
| 143 | PAK2 | 0.19382951 |
| 144 | FGFR4 | 0.18943544 |
| 145 | CAMK1 | 0.17480457 |
| 146 | MATK | 0.15682168 |
| 147 | ERBB3 | 0.14315734 |
| 148 | CAMK4 | 0.14261121 |
| 149 | ERBB4 | 0.13510019 |
| 150 | MAP3K6 | 0.13197992 |
| 151 | ERBB2 | 0.13046787 |
| 152 | SGK494 | 0.12732602 |
| 153 | SGK223 | 0.12732602 |
| 154 | MAPK9 | 0.12583069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Adherens junction_Homo sapiens_hsa04520 | 3.20894040 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.14285245 |
| 3 | Focal adhesion_Homo sapiens_hsa04510 | 2.35278326 |
| 4 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 2.33572544 |
| 5 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.29117743 |
| 6 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.27138824 |
| 7 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 2.23359836 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.06371847 |
| 9 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 2.02006390 |
| 10 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.99543098 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.79777841 |
| 12 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.78021948 |
| 13 | Prion diseases_Homo sapiens_hsa05020 | 1.77254707 |
| 14 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.76757815 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.74741723 |
| 16 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.73460087 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.73220299 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.71619966 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.67481659 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 1.66715321 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.62734163 |
| 22 | Tight junction_Homo sapiens_hsa04530 | 1.60459025 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.58843398 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.56770126 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55674337 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.54298562 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.53732727 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.53643031 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51328842 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48593431 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.47488682 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46878970 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.45773155 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 1.43417347 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.40421259 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39904756 |
| 37 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.37187851 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.36956460 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34146539 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.33928098 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33506551 |
| 42 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.33439854 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.27150087 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26162168 |
| 45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.25861793 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.25709715 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17617852 |
| 48 | Prostate cancer_Homo sapiens_hsa05215 | 1.17344047 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17149614 |
| 50 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.17030188 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14537103 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13210934 |
| 53 | Pathways in cancer_Homo sapiens_hsa05200 | 1.11965856 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 1.11141690 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10584217 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10078833 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09900508 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.08264238 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07723652 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.07386028 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06664663 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.06024772 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 1.05889248 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04360602 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.04171917 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02927411 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00765052 |
| 68 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99798625 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.98741438 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.97447045 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96317314 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95315607 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94675628 |
| 74 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93611914 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93008362 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91179539 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.89810929 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89438134 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.88836785 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87933463 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86379189 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86200939 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86171126 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85783541 |
| 85 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.84737378 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.84620190 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83439176 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80830087 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80703485 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79453451 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78466076 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.78446894 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73579142 |
| 94 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73456865 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.73342269 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72471056 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70176727 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.70111050 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69565355 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69493835 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68567491 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68488075 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.68301813 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68114242 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67684599 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.67003107 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66820486 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66775387 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63476255 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.62944083 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62244676 |
| 112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61127345 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59166298 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58825561 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58392312 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55868024 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55329692 |
| 118 | Long-term depression_Homo sapiens_hsa04730 | 0.54605564 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53736220 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53418704 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53239548 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.52874364 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52595064 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52225245 |
| 125 | Insulin secretion_Homo sapiens_hsa04911 | 0.49676053 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47757202 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47184625 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46969817 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46306998 |
| 130 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46281126 |
| 131 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46275528 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46262585 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46214870 |
| 134 | Measles_Homo sapiens_hsa05162 | 0.44568832 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41482965 |
| 136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41427914 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41047283 |

